Windlas Biotech Q4 Results
- BSE: 543329
- NSE: WINDLAS
- ISIN: INE0H5O01029
- Sector: Biotechnology & Drugs
BSE
739.20
-19.30 (-2.54%)
-19.30 (-2.54%)Volume665.00
Updated: Fri 6 Mar, 2026 | 15:24:07
NSE
745.00-10.05 (-1.33%)
-10.05 (-1.33%)Volume30.47 K
Updated: Fri 6 Mar, 2026 | 15:29:49
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Windlas Biotech Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 185.49 | 216.42 | 4.60% | 152.82 | 21.38% |
| Depreciation/ Amortization | 8.33 | 7.70 | 20.12% | 3.54 | 135.72% |
| Operating Income | 17.21 | 16.68 | -2.70% | 18.47 | -6.80% |
| Net Income | 16.28 | 15.00 | 4.53% | 16.99 | -4.19% |
| Other Operating Expenses Total | 20.04 | 23.18 | 15.27% | 19.28 | 3.95% |
| Net Income Before Taxes | 20.82 | 19.97 | 2.38% | 22.63 | -7.99% |
| Total Revenue | 202.70 | 233.10 | 3.94% | 171.29 | 18.34% |
| Selling/ General/ Admin Expenses Total | 31.93 | 42.05 | -0.76% | 22.85 | 39.73% |
| Diluted Normalized EPS | 7.67 | 7.05 | 3.88% | 8.07 | -5.06% |